$KRBP Kiromic BioPharma Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

on November 24, 2021 News and Tags: , , , with 0 comments
Time:
4:12 PM
Symbol:
KRBP
Source:
Business Wire News Releases
Read more

$KRBP Kiromic BioPharma, Now Clinical Stage, Reports Significant Progression Free Survival Benefit in Metastatic Pancreatic Cancer Patient Treated with KiroVax/BSK01, Company’s Phase 1 Cell Therapy Cancer V

on October 25, 2021 News and Tags: , , , with 0 comments
Time:
7:03 AM
Symbol:
KRBP
Source:
Business Wire News Releases
Read more

$KRBP Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid Cancers

on October 11, 2021 News and Tags: , , , with 0 comments
Time:
8:02 AM
Symbol:
KRBP
Source:
Business Wire News Releases
Read more

$KRBP Kiromic BioPharma Announces Chief Financial Officer Transition

on October 5, 2021 News and Tags: , , , with 0 comments
Time:
10:13 PM
Symbol:
KRBP
Source:
Business Wire News Releases
Read more

$KRBP Kiromic BioPharma Reports Second Quarter 2021 Financial Results and Operating Highlights

on August 13, 2021 News and Tags: , , , with 0 comments
Time:
3:32 PM
Symbol:
KRBP
Source:
Business Wire News Releases
Read more

$KRBP Kiromic Announces FDA IND Submission Forty-Five Days before the end of the Second Quarter: First-In-Human, Off-The-Shelf Chimeric PD1 Switch Receptor – Gamma Delta T-cell Therapy

on May 17, 2021 News and Tags: , , , with 0 comments
Time:
7:58 AM
Symbol:
KRBP
Source:
Business Wire News Releases
Read more

$KRBP Kiromic BioPharma Reports First Quarter 2021 Financial Results and Continued Corporate Progress

on May 14, 2021 News and Tags: , , , with 0 comments
Time:
12:50 PM
Symbol:
KRBP
Source:
Business Wire News Releases
Read more